ABC12: New drug kills metastatic melanoma
UC research looks at new drug that could improve treatments for metastatic melanoma
Doctors can often detect and treat early-stage melanoma, but when it advances, it is much tougher to fight and is fatal nearly half the time. Now a team of scientists at the University of Cincinnati is developing a combination therapy that can improve existing melanoma treatments.
Years of sun exposure or other UV light is a risk factor for melanoma, which can be deadly if not caught early.
“Melanoma, eventually, tends to go to the brain,” described Soma Sengupta, MD, PhD, a neuro-oncologist at the University of Cincinnati and UC Health.
“When it goes to the brain, it’s extremely challenging to treat,” explained Daniel Pomeranz Krummel, PhD, a researcher at the University of Cincinnati.
Read more about this research on UC News.
Featured photo of Pomeranz Krummel and Sengupta in their lab by Joe Fuqua/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
RevolutionUC hackathon highlights student ingenuity at 1819
March 14, 2025
The University of Cincinnati’s 1819 Innovation Hub recently hosted three of the Queen City’s premier hackathons: RevolutionUC, MakeUC and UC Startup Weekend.
UC chief digital officer named 2025 Ohio ORBIE Awards Enterprise...
March 14, 2025
University of Cincinnati’s Vice President & Chief Digital Officer Bharath Prabhakaran was named 2025 Ohio ORBIE Awards Enterprise CIO of the Year. This award recognizes Bharath’s leadership in digital transformation, fostering innovation, and enhancing student success at the University of Cincinnati.
UC joins novel bipolar research and clinical care network
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.